Mr. Ng Tse Meng Leads HCC Healthcare's Landmark Nasdaq SPAC Transaction Figure

Figure 1. Nasdaq Tower in Times Square, New York, congratulates HCC Healthcare and RF Acquisition Corp III on their announced business combination.

Press Release

Mr. Ng Tse Meng, Chief Advisor of DH Wealth Management (DHWM) and Chief Executive Officer of RF Acquisition Corp III (Nasdaq: RFAM), played a pivotal leadership role in HCC Healthcare's proposed Nasdaq listing through its business combination with RF Acquisition Corp III. The transaction values HCC Healthcare at approximately US$500 million. Upon completion,and subject to regulatory and shareholder approvals, HCC Healthcare is expected to become one of Asia's leading integrated healthcare and long-term care platforms listed on the Nasdaq Stock Market.

Figure 2. Representatives of HCC Healthcare and RF Acquisition Corp III at the business combination signing ceremony.

Drawing on extensive experience in cross-border capital markets, SPAC transactions, mergers and acquisitions, and corporate finance, Mr. Ng led the overall strategic planning, transaction structuring, and execution of the deal. His leadership has enabled HCC Healthcare to access international capital markets, supporting its expansion into integratedhealthcare, eldercare, AI-driven healthcare, precision medicine, and regenerative medicine across Asia.

Figure 3. Nasdaq Times Square display celebrating HCC Healthcare and RF Acquisition Corp III's announced merger.

Conclusion

This landmark transaction further reinforces Mr. Ng Tse Meng's proven track record in leading Nasdaq SPAC transactions and cross-border capital market initiatives. The prominent Nasdaq Times Square display underscores the significance of the transaction and highlights growing international recognition of HCC Healthcare's global growth strategy.